ProQR Therapeutics NV (PRQR)
1.93
+0.03
(+1.58%)
USD |
NASDAQ |
May 22, 16:00
1.93
0.00 (0.00%)
After-Hours: 20:00
ProQR Therapeutics Revenue (TTM): 11.18M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.18M |
| December 31, 2023 | 7.046M |
| September 30, 2023 | 4.245M |
| June 30, 2023 | 3.574M |
| March 31, 2023 | 3.250M |
| Date | Value |
|---|---|
| December 31, 2022 | 3.815M |
| September 30, 2022 | 3.330M |
| June 30, 2022 | 3.538M |
| March 31, 2022 | 2.841M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
2.841M
Minimum
Mar 2022
11.18M
Maximum
Mar 2024
4.757M
Average
3.574M
Median
Jun 2023
Revenue (TTM) Benchmarks
| uniQure NV | 19.00M |
| Merus NV | 38.34M |
| argenx SE | 1.408B |
| Pharming Group | 258.36M |
| Pharvaris NV | -- |